SEARCH

SEARCH BY CITATION

References

  • Berstein, I.D. (2000) Monoclonal antibodies to the myeloid stem cells. therapeutic implication of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate. Leukemia, 14, 474475.
  • Caron, P.C., Dumont, L., Scheinberg, D.A. (1998) Supersaturing infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia. Clinical Cancer Research, 4, 14211428.
  • De Vatten, M.P., Jansen, J.H., Van Der Reijden, B.A., Berger, M.S., Zijlmans, J.M., Lowenberg, B. (2000) Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozozgamicin, CMA-676). British Journal of Haematology, 111, 277279.DOI: 10.1046/j.1365-2141.2000.02402.x
  • Dinndorf, P.A., Andrews, R.G., Benjamin, D., Ridgway, D., Wolff, L., Bernstein, I.D. (1986) Expression of normal myeloid-associated antigens by acute leukemia cells. Blood, 67, 10481053.
  • Jurcic, J.G., DeBlasio, T., Dumont, L., Yao, T.J., Scheinberg, D.A. (2000) Molecular remission induction with retinoic acid and Anti-Cd33 monoclonal antibody HuM195 in acute promyelocytic leukaemia. Clinical Cancer Research, 6, 372380.
  • Lo Coco, F., Diverio, D., Avvisati, G., Petti, M.C., Meloni, G., Pogliani, E.M., Biondi, A., Rossi, G., Carlo-Stella, C., Selleri, C., Martino, B., Specchia, G., Mandelli, F. (1999) Therapy of molecular relapse in acute promyelocytic leukemia. Blood, 94, 22252229.
  • Mandelli, F., Diverio, D., Avvisati G., Luciano, A., Barbui, T., Bernasconi, C., Broccia, G., Cerri, R., Falda, M., Fioritoni, G., Leoni, F., Liso, V., Petti, M.C., Rodeghiero, F., Saglio, G., Vegna, M.L., Visani, G., Jehn, U., Willemze, R., Muus, P., Pelicci, P.G., Biondi, A., Lo Coco, F. (1997) Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood, 90, 10141021.
  • Michieli, M., Damiani, D., Ermacora, A., Geromin, A., Michelutti, A., Masolini, P., Baccarani, M. (2000) P-glycoprotein (PGP), lung-resistance related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia. British Journal of Haematology, 108, 703709.
  • Sievers, E., Appelbaum, F.R., Spielberger, R.T., Forman, S.J., Flowers, D., Smith, F.O., Shannon-Dorcy, K., Berger, M.S., Bernstein, I.D. (1999) Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of anti-CD33 calicheamicin immunoconjugate. Blood, 93, 36783684.
  • Takeshita, A. & Ohno, R. (1996) Multidrug resistance in acute leukaemia. Risho Ketsurki, 37, 640646.
  • Zein, N., Sinha, A.N., McGaren, W.J., Ellestad, G.A. (1988) Callicheamicin gamma 11: an antitumor antibiotic that cleaves double-stranded DANN site specifically. Science, 240, 11981201.